- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ultrasound-guided laser targets Europe
Intra-Sonix of Burlington, MA, has initiated clinical trials in Germany and Belgium for itsTulip II ultrasound-guided minimally invasive surgery device.Tulip,an earlier generation product, is already approved for marketin Europe and Japan. Intra-Sonix
Intra-Sonix of Burlington, MA, has initiated clinical trials in Germany and Belgium for itsTulip II ultrasound-guided minimally invasive surgery device.Tulip,an earlier generation product, is already approved for marketin Europe and Japan. Intra-Sonix operates a European subsidiarybased in Leuven, Belgium.
The Tulip procedure -- transurethral ultrasound-guided laser-inducedprostatectomy -- provides treatment of benign prostatic hyperplasia(BPH). Tulip II offers full 360º ultrasound viewing of theprostate along with other system upgrades. Worldwide, more thanone million men undergo surgical treatment of BPH annually, thecompany said.
Use of ultrasound imaging indicates tissue depth and anatomicalfeatures while treating BPH with laser surgery. This can helpsurgeons determine which obstructive prostate tissue to target-- and which not to target -- thus expanding the number of potentiallytreatable prostates. The laser causes necrosis of tissue, whichis subsequently sloughed off in small particles during urination.
Intra-Sonix has also initiated a new six-site U.S. clinicalstudy of Tulip, following reclassification of laser treatmentsfor BPH by the Food and Drug Administration last year. An investigationaldevice exemption application has been filed with the FDA for TulipII.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
